Trials / Active Not Recruiting
Active Not RecruitingNCT06592716
Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?
Specificity and Sensitivity of Circulating HPV-DNA in Patients With Oropharyngeal Squamous Cell Carcinoma
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates if longitudinal analyses of cell-free HPV-DNA in blood samples can be utilized to detect recurrence in patients diagnosed and treated for HPV-positive oropharyngeal squamous cell carcinoma.
Conditions
- Oropharynx Cancer
- Oropharynx Cancer, Metastatic
- Oropharynx Cancer, Recurrent
- Oropharyngeal Carcinoma
- Oropharyngeal Squamous Cell Carcinoma (OPSCC)
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Liquid biopsy | The intervention is a liquid biopsy as a blood sample taken in a peripheral vein. The blood samples are analyzed for ctHPV-DNA. |
Timeline
- Start date
- 2024-04-02
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
- First posted
- 2024-09-19
- Last updated
- 2025-11-18
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT06592716. Inclusion in this directory is not an endorsement.